ArticleCureus2022
The Impact of the COVID-19 Pandemic on Diagnosis of Skin Cancer Cases in North Cancer Alliance and Scotland.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 2 syntheses or guidelines pooled it, 4 citations in OpenAlex.
- The global impact of the COVID-19 pandemic on delays and disruptions in cancer care services: a systematic review and meta-analysis.Nature cancer · 2025Pooled it
- The Epidemiology of Malignant Melanoma during the First Two Years of the COVID-19 Pandemic: A Systematic Review.International journal of environmental research and public health · 2022Pooled it
- Epidemiology of Non-Melanoma Skin Cancer in Europe over the Last Decade: A Systematic Review.Cancers · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has dramatically impacted healthcare provision in the UK and skin cancer services have had to adapt to ensure continuity of safe care. As we return to "normality" we reflect on lessons learned and the impact of the pandemic on skin cancer services. We looked at data on Public Health Scotland Dashboard, which compiles data from 14 local health boards across Scotland, comparing melanoma and non-melanoma skin cancer diagnoses during the years 2020 and 2019 (pre-COVID-19 pandemic). We looked at skin cancer cases within the North Cancer Alliance (NCA) and all of Scotland. Within the NCA, 518 cases of melanoma were diagnosed in 2019, compared to 429 in 2020. Within Scotland, 1950 cases of melanoma were diagnosed in 2019, compared to 1605 in 2020. In 2019, 5103 non-melanoma skin cancer cases were diagnosed in NCA, compared to 4071 in 2020. In Scotland, 21,626 non-melanoma skin cancer cases were diagnosed in 2019, compared to 16,193 in 2020. The COVID-19 pandemic has had a significant impact on skin cancer care within the NCA and the whole of Scotland. A significantly lower number of melanoma and non-melanoma skin cancer cases have been diagnosed within the NCA and in Scotland in 2020 compared to 2019. The trend is similar between NCA and other areas of Scotland. We must raise awareness of melanoma and non-melanoma skin cancer to improve timely presentation of patients during a global health crisis and a multidisciplinary approach is needed to address this problem.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.